CN112080558B - 同时检测hba1/2和hbb基因突变的试剂盒和方法 - Google Patents
同时检测hba1/2和hbb基因突变的试剂盒和方法 Download PDFInfo
- Publication number
- CN112080558B CN112080558B CN201910514793.1A CN201910514793A CN112080558B CN 112080558 B CN112080558 B CN 112080558B CN 201910514793 A CN201910514793 A CN 201910514793A CN 112080558 B CN112080558 B CN 112080558B
- Authority
- CN
- China
- Prior art keywords
- ext
- hba1
- gext
- hbb
- mutations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102100027685 Hemoglobin subunit alpha Human genes 0.000 title claims abstract description 85
- 101001009007 Homo sapiens Hemoglobin subunit alpha Proteins 0.000 title claims abstract description 71
- 101150013707 HBB gene Proteins 0.000 title claims abstract description 55
- 101150028074 2 gene Proteins 0.000 title claims abstract description 50
- 206010064571 Gene mutation Diseases 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title abstract description 33
- 238000007403 mPCR Methods 0.000 claims abstract description 24
- 230000003321 amplification Effects 0.000 claims abstract description 21
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 21
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 18
- 239000012634 fragment Substances 0.000 claims abstract description 11
- 230000035772 mutation Effects 0.000 claims description 64
- 230000037430 deletion Effects 0.000 claims description 31
- 238000012217 deletion Methods 0.000 claims description 31
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 claims description 21
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 101150052743 Hba1 gene Proteins 0.000 claims description 11
- 101150116759 HBA2 gene Proteins 0.000 claims description 7
- 239000011324 bead Substances 0.000 claims description 5
- 239000011535 reaction buffer Substances 0.000 claims description 4
- 102000012410 DNA Ligases Human genes 0.000 claims description 2
- 108010061982 DNA Ligases Proteins 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 2
- 108060002716 Exonuclease Proteins 0.000 claims description 2
- 102000013165 exonuclease Human genes 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 1
- 238000012163 sequencing technique Methods 0.000 description 23
- 108020004414 DNA Proteins 0.000 description 21
- 238000001514 detection method Methods 0.000 description 17
- 239000000523 sample Substances 0.000 description 14
- 108091005902 Hemoglobin subunit alpha Proteins 0.000 description 10
- 238000011144 upstream manufacturing Methods 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 9
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 8
- 238000010276 construction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002096 quantum dot Substances 0.000 description 6
- 108091023037 Aptamer Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 208000002903 Thalassemia Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000012149 elution buffer Substances 0.000 description 3
- 108091008053 gene clusters Proteins 0.000 description 3
- 102000018146 globin Human genes 0.000 description 3
- 108060003196 globin Proteins 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 201000006288 alpha thalassemia Diseases 0.000 description 2
- 208000005980 beta thalassemia Diseases 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000012224 gene deletion Methods 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 101150096316 5 gene Proteins 0.000 description 1
- 101150101112 7 gene Proteins 0.000 description 1
- 102100022749 Aminopeptidase N Human genes 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102100022002 CD59 glycoprotein Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- -1 DNA repair cocktail Substances 0.000 description 1
- 241000531123 GB virus C Species 0.000 description 1
- 101710128747 Hemoglobin subunit alpha-A Proteins 0.000 description 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 1
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
- 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 1
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102100039564 Leukosialin Human genes 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
- 108091008109 Pseudogenes Proteins 0.000 description 1
- 102000057361 Pseudogenes Human genes 0.000 description 1
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000021024 autosomal recessive inheritance Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 102220358515 c.95G>A Human genes 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000008143 early embryonic development Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 102220004888 rs121913665 Human genes 0.000 description 1
- 102200067541 rs281864846 Human genes 0.000 description 1
- 102200071415 rs41397847 Human genes 0.000 description 1
- 102220005325 rs41464951 Human genes 0.000 description 1
- 102200071416 rs41479347 Human genes 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
引物序列号 | 引物名称 | 引物序列(5’-3’) |
SEQ ID NO.1 | WT-F | TCCTCACCCCACATCCCCTCACCTACATTCTGCA |
SEQ ID NO.2 | WT-R | GCAGGAGGAACGGCTACCGAG |
SEQ ID No.3 | 3.7-F | TCCTCACCCCACATCCCCTCACCTACATTCTGCA |
SEQ ID No.4 | 3.7-R | TGGACTTCGCGGTGGCTCCACTTTCCCTC |
SEQ ID NO.5 | 4.2-F | AAGCTAGAGCATTGGTGGTCAT |
SEQ ID No.6 | 4.2-R | TGAGGCGGAGTTTCGCTG |
SEQ ID No.7 | SEA-F | AATGGATGAGGACGGAGCGA |
SEQ ID No.8 | SEA-R | ACGTTGTGTTCATGGCTGTG |
SEQ ID No.9 | HBB-F | GAGGGAGGGCTGAGGGTYTG |
SEQ ID No.10 | HBB-R | GGGTGGGCCTATGAYAGGGT |
编号 | HGVs命名 | 碱基改变 |
1 | HBA2:c.40G>T | CD13(G-T) |
2 | HBA2:c.91_93de1GAG | CD30(-GAG) |
3 | HBA2:c.95G>A | CD31(G-A) |
4 | HBA2:c.133delC | CD43/44(-C) |
5 | HBA2:c.149_150delGC | CD49(-GC) |
6 | HBA2:c.179G>A | CD59(G-A) |
7 | HBA2:c.369C>G | WS(CD122(C-G)) |
8 | HBA2:c.377T>C | QS(CD125(T-C)) |
9 | HBA2:c.427T>C | CS(CD142(T-C)) |
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910514793.1A CN112080558B (zh) | 2019-06-13 | 2019-06-13 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
PCT/CN2020/095895 WO2020249102A1 (zh) | 2019-06-13 | 2020-06-12 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910514793.1A CN112080558B (zh) | 2019-06-13 | 2019-06-13 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112080558A CN112080558A (zh) | 2020-12-15 |
CN112080558B true CN112080558B (zh) | 2024-03-12 |
Family
ID=73733870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910514793.1A Active CN112080558B (zh) | 2019-06-13 | 2019-06-13 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112080558B (zh) |
WO (1) | WO2020249102A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112080558B (zh) * | 2019-06-13 | 2024-03-12 | 杭州贝瑞和康基因诊断技术有限公司 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
CN112708674B (zh) * | 2021-03-29 | 2021-06-29 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2和hbb基因位点多种突变的方法和试剂盒 |
CN114561460A (zh) * | 2021-12-30 | 2022-05-31 | 广西医科大学第二附属医院(广西医科大学第二临床医学院) | 一种检测断裂位点未明的罕见β地中海贫血基因大片段缺失的引物组、试剂盒及测序文库 |
WO2024010812A2 (en) * | 2022-07-07 | 2024-01-11 | Illumina Software, Inc. | Methods and systems for determining copy number variant genotypes |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137806A (en) * | 1989-12-11 | 1992-08-11 | Board Of Regents, The University Of Texas System | Methods and compositions for the detection of sequences in selected DNA molecules |
US5750345A (en) * | 1995-10-31 | 1998-05-12 | Evanston Hospital Corporation | Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders |
CN102409100A (zh) * | 2011-11-29 | 2012-04-11 | 潮州市中心医院 | 地中海贫血实时荧光定量pcr检测引物和试剂盒 |
CN103255225A (zh) * | 2013-05-27 | 2013-08-21 | 钦州市妇幼保健院 | 一种基于荧光标记定量pcr技术的地中海贫血基因检测方法 |
WO2014018080A1 (en) * | 2012-07-24 | 2014-01-30 | Natera, Inc. | Highly multiplex pcr methods and compositions |
CN104212910A (zh) * | 2014-09-28 | 2014-12-17 | 广东凯普生物科技股份有限公司 | 单管扩增同时检测α和β地中海贫血基因试剂盒 |
CN104745679A (zh) * | 2013-12-31 | 2015-07-01 | 北京贝瑞和康生物技术有限公司 | 一种无创检测egfr基因突变的方法及试剂盒 |
CN105420233A (zh) * | 2015-12-08 | 2016-03-23 | 海南医学院附属医院 | Hbb基因突变和hla分型检测试剂盒 |
CN106755329A (zh) * | 2016-11-28 | 2017-05-31 | 广西壮族自治区妇幼保健院 | 基于二代测序技术检测α和β地中海贫血点突变的方法及试剂盒 |
CN107794575A (zh) * | 2017-10-16 | 2018-03-13 | 深圳华大基因股份有限公司 | 用于Pacbio平台的DNA大片段文库构建方法和试剂盒 |
CN108642160A (zh) * | 2018-05-16 | 2018-10-12 | 广州市达瑞生物技术股份有限公司 | 检测胎儿地中海贫血致病基因的方法和试剂盒 |
CN108796054A (zh) * | 2018-09-14 | 2018-11-13 | 华大生物科技(武汉)有限公司 | 用于同时检测地中海贫血基因突变型与缺失型的试剂盒及其应用 |
CN108796061A (zh) * | 2017-11-07 | 2018-11-13 | 深圳华大临床检验中心有限公司 | 用于地中海贫血突变型基因检测的引物组、试剂盒、其应用及文库构建方法 |
CN109056077A (zh) * | 2018-09-13 | 2018-12-21 | 武汉菲沙基因信息有限公司 | 一种适用于PacBio测序平台的扩增子混样测序文库构建方法 |
CN109112201A (zh) * | 2017-06-23 | 2019-01-01 | 陈治中 | 一种单管检测非缺失α与β地中海贫血的基因芯片、引物组及试剂盒 |
CN110592208A (zh) * | 2019-10-08 | 2019-12-20 | 北京诺禾致源科技股份有限公司 | 地中海贫血症三类亚型的捕获探针组合物及其应用方法和应用装置 |
WO2020249102A1 (zh) * | 2019-06-13 | 2020-12-17 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
CN112708674A (zh) * | 2021-03-29 | 2021-04-27 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2和hbb基因位点多种突变的方法和试剂盒 |
CN113564248A (zh) * | 2021-09-26 | 2021-10-29 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2、hbb和hbd基因位点多种突变的方法和试剂盒 |
KR102368835B1 (ko) * | 2020-09-28 | 2022-03-02 | 한경대학교 산학협력단 | 한우의 육량 관련 hspb1 유전자의 유전형 결정용 프라이머 세트 및 이의 용도 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180201998A1 (en) * | 2015-07-14 | 2018-07-19 | Capitalbio Corporation | Compositions and methods for detection of genetic deafness gene mutation |
US11118229B2 (en) * | 2019-01-25 | 2021-09-14 | Imam Abdulrahman Bin Faisal University | Single tube multiplex PCR method for the detection of HBA1, HBA2 and HBA12 genes |
-
2019
- 2019-06-13 CN CN201910514793.1A patent/CN112080558B/zh active Active
-
2020
- 2020-06-12 WO PCT/CN2020/095895 patent/WO2020249102A1/zh active Application Filing
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137806A (en) * | 1989-12-11 | 1992-08-11 | Board Of Regents, The University Of Texas System | Methods and compositions for the detection of sequences in selected DNA molecules |
US5750345A (en) * | 1995-10-31 | 1998-05-12 | Evanston Hospital Corporation | Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders |
CN102409100A (zh) * | 2011-11-29 | 2012-04-11 | 潮州市中心医院 | 地中海贫血实时荧光定量pcr检测引物和试剂盒 |
WO2014018080A1 (en) * | 2012-07-24 | 2014-01-30 | Natera, Inc. | Highly multiplex pcr methods and compositions |
CN103255225A (zh) * | 2013-05-27 | 2013-08-21 | 钦州市妇幼保健院 | 一种基于荧光标记定量pcr技术的地中海贫血基因检测方法 |
CN104745679A (zh) * | 2013-12-31 | 2015-07-01 | 北京贝瑞和康生物技术有限公司 | 一种无创检测egfr基因突变的方法及试剂盒 |
CN104212910A (zh) * | 2014-09-28 | 2014-12-17 | 广东凯普生物科技股份有限公司 | 单管扩增同时检测α和β地中海贫血基因试剂盒 |
CN105420233A (zh) * | 2015-12-08 | 2016-03-23 | 海南医学院附属医院 | Hbb基因突变和hla分型检测试剂盒 |
CN106755329A (zh) * | 2016-11-28 | 2017-05-31 | 广西壮族自治区妇幼保健院 | 基于二代测序技术检测α和β地中海贫血点突变的方法及试剂盒 |
CN109112201A (zh) * | 2017-06-23 | 2019-01-01 | 陈治中 | 一种单管检测非缺失α与β地中海贫血的基因芯片、引物组及试剂盒 |
CN107794575A (zh) * | 2017-10-16 | 2018-03-13 | 深圳华大基因股份有限公司 | 用于Pacbio平台的DNA大片段文库构建方法和试剂盒 |
CN108796061A (zh) * | 2017-11-07 | 2018-11-13 | 深圳华大临床检验中心有限公司 | 用于地中海贫血突变型基因检测的引物组、试剂盒、其应用及文库构建方法 |
CN108642160A (zh) * | 2018-05-16 | 2018-10-12 | 广州市达瑞生物技术股份有限公司 | 检测胎儿地中海贫血致病基因的方法和试剂盒 |
CN109056077A (zh) * | 2018-09-13 | 2018-12-21 | 武汉菲沙基因信息有限公司 | 一种适用于PacBio测序平台的扩增子混样测序文库构建方法 |
CN108796054A (zh) * | 2018-09-14 | 2018-11-13 | 华大生物科技(武汉)有限公司 | 用于同时检测地中海贫血基因突变型与缺失型的试剂盒及其应用 |
WO2020249102A1 (zh) * | 2019-06-13 | 2020-12-17 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
CN110592208A (zh) * | 2019-10-08 | 2019-12-20 | 北京诺禾致源科技股份有限公司 | 地中海贫血症三类亚型的捕获探针组合物及其应用方法和应用装置 |
KR102368835B1 (ko) * | 2020-09-28 | 2022-03-02 | 한경대학교 산학협력단 | 한우의 육량 관련 hspb1 유전자의 유전형 결정용 프라이머 세트 및 이의 용도 |
CN112708674A (zh) * | 2021-03-29 | 2021-04-27 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2和hbb基因位点多种突变的方法和试剂盒 |
WO2022206573A1 (zh) * | 2021-03-29 | 2022-10-06 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2和hbb基因位点多种突变的方法和试剂盒 |
CN113564248A (zh) * | 2021-09-26 | 2021-10-29 | 北京贝瑞和康生物技术有限公司 | 同时检测hba1/2、hbb和hbd基因位点多种突变的方法和试剂盒 |
Non-Patent Citations (3)
Title |
---|
Long-Molecule Sequencing A New Approach for Identification of Clinically Significant DNA Variants in a-Thalassemia and b-Thalassemia Carriers;Liangpu Xu等;《The Journal of Molecular Diagnostics》;第22卷(第8期);第1087-1095页 * |
Multi-allele DNA biosensor for the rapid genotyping of ‘nondeletion’ alpha thalassaemia mutations in HBA1 and HBA2 genes by means of multiplex primer extension reaction;Margarita Petropoulou 等;《Clinica Chimica Acta》;第446卷(第15期);第241-247页 * |
基于高通量测序技术检测地中海贫血突变型和缺失型的方法建立;杨晓琴;中国优秀硕士学位论文全文数据库 医药卫生科技辑;E062-206 * |
Also Published As
Publication number | Publication date |
---|---|
WO2020249102A1 (zh) | 2020-12-17 |
CN112080558A (zh) | 2020-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112080558B (zh) | 同时检测hba1/2和hbb基因突变的试剂盒和方法 | |
CN106755501B (zh) | 一种基于二代测序的同时检测微卫星位点稳定性和基因组变化的方法 | |
CN112397144B (zh) | 检测基因突变及表达量的方法及装置 | |
JP2020000237A (ja) | まれな変異およびコピー数多型を検出するためのシステムおよび方法 | |
WO2023045750A1 (zh) | 同时检测先天性肾上腺皮质增生症相关9个基因多种突变的引物组和试剂盒 | |
WO2022206573A1 (zh) | 同时检测hba1/2和hbb基因位点多种突变的方法和试剂盒 | |
CN114317728B (zh) | 用于检测sma中多种突变的引物组、试剂盒、方法和系统 | |
CN113889187A (zh) | 单样本等位基因拷贝数变异检测方法、探针组和试剂盒 | |
CN115948532A (zh) | 基于数字pcr技术的sma检测试剂盒 | |
CN116716397A (zh) | 检测dmd基因变异的方法及装置和探针、试剂盒 | |
CN112195238B (zh) | 一种扩增pkd1基因的引物组及试剂盒 | |
CN111020019B (zh) | 基于纳米孔技术进行基因融合检测的方法 | |
CN112442530B (zh) | 检测cah相关真假基因的方法 | |
CN116287198A (zh) | 一种检测多种疾病相关基因突变类型的引物组、试剂盒和方法 | |
CN102703440A (zh) | 山羊sh2b1基因单核苷酸多态性位点及其检测方法 | |
CN115029430A (zh) | 一组评估主动脉夹层风险的生物标志物及其应用 | |
CN113957140A (zh) | 一种检测中国型Gγ+(Aγδβ)0地中海贫血缺失变异的引物组,试剂盒及方法 | |
CN111471755B (zh) | 用于微卫星不稳定性检测的生物标志物组合、试剂盒及其用途 | |
Verma et al. | Hemoglobinopathies in India—clinical and laboratory aspects | |
CN113943785B (zh) | 一种检测东南亚型hpfh缺失变异的引物组、试剂盒及方法 | |
CN117143997B (zh) | 一种用于pkd1基因突变检测的引物组、试剂盒及检测方法 | |
CN116855606B (zh) | 心脏粘液瘤的基因突变体、检测引物及试剂盒 | |
CN113801946B (zh) | 一种影响母猪繁殖性能的分子标记、检测方法及其应用 | |
CN115992219A (zh) | Tomm6突变基因、检测其的引物、试剂盒和方法以及其用途 | |
CN117126867A (zh) | Timm10b突变基因、检测其的引物、试剂盒和方法以及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40040633 Country of ref document: HK |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20220111 Address after: 310018 first and second floors of Building 9 and 16, No. 260, No. 6 street, Baiyang street, Hangzhou Economic and Technological Development Zone, Hangzhou, Zhejiang Province Applicant after: Hangzhou Berry Hekang Gene Diagnosis Technology Co.,Ltd. Address before: 102299 8th Floor 801, No. 5 Building, No. 4 Life Garden Road, Changping District Science Park, Beijing Applicant before: BERRY GENOMICS Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |